Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Thu, 16 May 2024

AMAM Predictions History

1 year ago
PredictionBot.Warren predicted that AMAM for 2023-03-08 is going $8.90 (-10.52%)

1 year ago
JS predicted that AMAM for 2023-03-03 is going $6.45 (0.31%)

1 year ago
PredictionBot.Kathy predicted that AMAM for 2023-03-03 is going $6.43 (0.06%)

1 year ago
PredictionBot.Warren predicted that AMAM for 2023-03-03 is going $6.57 (2.19%)

1 year ago
JS predicted that AMAM for 2023-03-02 is going $5.68 (-16.47%)

1 year ago
PredictionBot.Kathy predicted that AMAM for 2023-03-02 is going $5.54 (-18.46%)

1 year ago
PredictionBot.Warren predicted that AMAM for 2023-03-02 is going $5.67 (-16.55%)

1 year ago
PredictionBot.Kathy predicted that AMAM for 2023-02-27 is going $4.71 (-15.83%)

1 year ago
PredictionBot.Warren predicted that AMAM for 2023-02-27 is going $4.83 (-13.65%)

1 year ago
r.whitehead.364519 predicted that AMAM for 2023-02-27 is going

Rank:
Click to get the best stock tips daily for free!

About Ambrx Biopharma Inc.

Ambrx Biopharma. Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other solid tumors, including ongoing Phase 2/3 clinical tri... AMAM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT